Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 424 of 1,261
  1. US 10646537

    Traditional Chinese medicine for treating abdominal obesity

    INFINITUS (CHINA) COMPANY LTD. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  2. US 10646481

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2020 · Expires May 7, 2040

    granted
  3. US 10646577

    mTORC1 inhibitors

    The Regents of the University of California · Granted May 12, 2020 · Expires May 7, 2040

    granted
  4. US 10646555

    Compositions and methods relating to argininosuccinate synthetase

    BioRegency, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  5. US 10649053

    Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices

    The Regents of the University of California · Granted May 12, 2020 · Expires May 7, 2040

    granted
  6. US 10647964

    Non-neuroinvasive viruses and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 12, 2020 · Expires May 7, 2040

    granted
  7. US 10648001

    Method of treating mucopolysaccharidosis type I or II

    Sangamo Therapeutics, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  8. US 10647754

    Stabilized single human CD4 domains and fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2020 · Expires May 7, 2040

    granted
  9. US 10647720

    Pyrimido-pyridazinone compounds and methods of use thereof

    Asana BioSciences, LLC · Granted May 12, 2020 · Expires May 7, 2040

    granted
  10. US 10647689

    Apelin receptor agonists and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted May 12, 2020 · Expires May 7, 2040

    granted
  11. US 10647715

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  12. US 10647661

    Carboxamides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2020 · Expires May 7, 2040

    granted
  13. US 10647658

    Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same

    The Regents of the University of California · Granted May 12, 2020 · Expires May 7, 2040

    granted
  14. US 10646591

    Imaging agents for imaging protease activity and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2020 · Expires May 7, 2040

    granted
  15. US 10646578

    Polymer derivatives having particular atom arrangements

    Nektar Therapeutics · Granted May 12, 2020 · Expires May 7, 2040

    granted
  16. US 10647785

    High concentration chitosan-nucleic acid polyplex compositions

    ENGENE, INC. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  17. US 10646593

    Activatable membrane-interacting peptides and methods of use

    The Regents of the University of California · Granted May 12, 2020 · Expires May 7, 2040

    granted
  18. US 10646588

    RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2020 · Expires May 7, 2040

    granted
  19. US 10646574

    Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same

    The Board of Regents of the University of Texas System · Granted May 12, 2020 · Expires May 7, 2040

    granted
  20. US 10646557

    Vaccine composition

    TURNSTONE LIMITED PARTNERSHIP · Granted May 12, 2020 · Expires May 7, 2040

    granted
  21. US 10646543

    Methods and compositions for treating trinucleotide repeat disorders

    Sangamo Therapeutics, Inc. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  22. US 10646550

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    BIOMARIN PHARMACEUTICAL INC. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  23. US 10646534

    Formulation, preparation method and use of Chinese herbal medicine composition for soothing liver

    INFINITUS (CHINA) COMPANY LTD. · Granted May 12, 2020 · Expires May 7, 2040

    granted
  24. US 10646523

    Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions

    AGAIN LIFE ITALIA SRL · Granted May 12, 2020 · Expires May 7, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.